0 0 0 0 0 0 0 0
Thanks for submitting the form.
Stockreport

Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight [Yahoo! Finance]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Financial performance highlights potential challenges and growth opportunities for Gilead Sciences Inc. Detailed examination of Gilead Sciences Inc's strengths, weaknesses, opportunities, and threats to inform investment decisions. Gilead Sciences Inc ( NASDAQ:GILD ) recently filed its 10-Q report on November 12, 2024, providing a snapshot of the company's financial health and strategic positioning. The report reveals a 7% increase in total revenues to $7.5 billion for the three months ended September 30, 2024, compared to the same period in 2023, primarily driven by higher product sales in HIV. However, net income attributable to Gilead saw a significant decrease from $2.2 billion in Q3 2023 to $1.3 billion in Q3 2024, with diluted earnings per share dropping from $1.73 to $1.00. This decline is largely attributed to a substantial in-process research and development (IPR&D) impairment charge related to assets acquired from Immunomedics in 2020. Despite this setback, Gilead Scien [Read more]

IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Stockreport

Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Financial performance highlights potential challenges and growth opportunities for Gilead Sciences Inc. Detailed examination of Gilead Sciences Inc's strengths, weaknesses, opportunities, and threats to inform investment decisions. Gilead Sciences Inc ( NASDAQ:GILD ) recently filed its 10-Q report on November 12, 2024, providing a snapshot of the company's financial health and strategic positioning. The report reveals a 7% increase in total revenues to $7.5 billion for the three months ended September 30, 2024, compared to the same period in 2023, primarily driven by higher product sales in HIV. However, net income attributable to Gilead saw a significant decrease from $2.2 billion in Q3 2023 to $1.3 billion in Q3 2024, with diluted earnings per share dropping from $1.73 to $1.00. This decline is largely attributed to a substantial in-process research and development (IPR&D) impairment charge related to assets acquired from Immunomedics in 2020. Despite this setback, Gilead Scien [Read more]

IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS